Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vor Biopharma Inc (NQ: VOR ) 0.9700 +0.0080 (+0.83%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vor Biopharma Inc < Previous 1 2 3 4 5 Next > Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 During Tuesday's session, 275 companies made new 52-week lows. Via Benzinga Vor Bio to Participate in Upcoming Investor Conferences August 30, 2023 From Vor Biopharma Via GlobeNewswire The Latest Analyst Ratings for Vor Biopharma August 14, 2023 Via Benzinga What 11 Analyst Ratings Have To Say About Vor Biopharma June 12, 2023 Via Benzinga 8 Analysts Have This to Say About Vor Biopharma May 15, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Friday August 11, 2023 During the Friday's sesion, 157 stocks hit new 52-week lows. Via Benzinga Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update August 10, 2023 From Vor Biopharma Via GlobeNewswire Vor Biopharma: Q1 Earnings Insights May 11, 2023 Via Benzinga Where Vor Biopharma Stands With Analysts March 24, 2023 Via Benzinga Truist Securities Maintains Buy Rating for Vor Biopharma: Here's What You Need To Know March 24, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Thursday August 10, 2023 On Thursday, 128 companies set new 52-week lows. Via Benzinga Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference August 01, 2023 From Vor Biopharma Via GlobeNewswire Stocks That Hit 52-Week Lows On Wednesday July 05, 2023 Wednesday's session saw 43 companies set new 52-week lows. Via Benzinga Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July July 05, 2023 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients June 09, 2023 Vor Biopharma Inc (NASDAQ: VOR) presented updated data from patients treated in the VBP101 Phase 1/2a study of trem-cel (formerly VOR33) in Via Benzinga Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform June 09, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in the Goldman Sachs Healthcare Conference June 05, 2023 From Vor Biopharma Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023 May 16, 2023 Via Benzinga Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update May 11, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in Upcoming Investor Conferences April 18, 2023 From Vor Biopharma Via GlobeNewswire Dow Rises 50 Points; Oxford Industries Shares Plunge March 24, 2023 U.S. stocks pared some losses toward the end of trading, with the Dow Jones and S&P 500 turning higher on Friday. The Dow traded up 0.16% to 32,156.53 while the NASDAQ fell 0.16% to 11,768.17. The S&P... Via Benzinga Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session March 24, 2023 Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. Via Benzinga Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update March 23, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in Upcoming Investor Conferences February 21, 2023 From Vor Biopharma Via GlobeNewswire Vor Biopharma's Leukemia Cell Exhibits Favorable Engraftment Five Months Post-Transplant February 16, 2023 Via Benzinga First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level February 16, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings January 19, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference January 12, 2023 From Vor Biopharma Via GlobeNewswire Analyzing Vor Biopharma's Short Interest January 10, 2023 Vor Biopharma's (NASDAQ:VOR) short percent of float has fallen 58.58% since its last report. The company recently reported that it has 2.53 million shares sold short, which is 5.31% of all regular... Via Benzinga Dow Edges Higher; Prometheus Biosciences Shares Jump December 07, 2022 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.